Clinical Research and Translation
The Riddell Centre's Clinical Research and Translation program is dedicated to advancing the development of experimental cell therapy products, prioritizing those developed within the Centre, and improving upon the safety and efficacy of approved cell therapy products for cancer patients. This program will work closely with existing clinical research units for both adult and pediatric patients, ensuring seamless collaboration while staying open to new opportunities in cell therapy research.
Our objectives in Clinical Research and Translation include:
Clinical Trials
At the Riddell Centre, our mission is to develop innovative immunotherapies for patients with high unmet needs, and rapidly translate those into early-phase clinical trials.
Learn more about our upcoming Phase 1 feasibility and safety trial, studying GCAR1 - a CAR T-cell therapy for patients with relapsed / refractory GPNMB expressing solid tumors:
